Royal Bank Of Canada Acutus Medical, Inc. Transaction History

Royal Bank Of Canada

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Nov 05, 2024	BUY	$0.17 - $0.31 $42 - $78	252 New	252 $0
Q1 2024 May 15, 2024	SELL	$0.17 - $0.31 $20 - $38	-123 Reduced 32.8%	252 $0
Q4 2023 Feb 14, 2024	BUY	$0.17 - $0.74 $26 - $116	158 Added 72.81%	375 $0
Q3 2023 Nov 14, 2023	SELL	$0.47 - $0.89 $10 - $19	-22 Reduced 9.21%	217 $0
Q2 2023 Aug 14, 2023	BUY	$0.66 - $1.02 $103 - $160	157 Added 191.46%	239 $0
Q1 2023 May 15, 2023	SELL	$0.7 - $1.87 $135 - $360	-193 Reduced 70.18%	82 $0
Q4 2022 Feb 14, 2023	BUY	$0.62 - $1.15 $127 - $236	206 Added 298.55%	275 $0
Q3 2022 Nov 14, 2022	BUY	$0.76 - $1.66 $52 - $114	69 New	69 $0
Q2 2022 Aug 15, 2022	SELL	$0.49 - $1.3 $5,965 - $15,826	-12,174 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.39 - $3.92 $9,424 - $26,577	6,780 Added 125.7%	12,174 $17,000
Q4 2021 Feb 14, 2022	SELL	$3.1 - $8.97 $1,047 - $3,031	-338 Reduced 5.9%	5,394 $18,000
Q3 2021 Nov 15, 2021	BUY	$8.35 - $16.99 $16,608 - $33,793	1,989 Added 53.14%	5,732 $51,000
Q2 2021 Aug 16, 2021	BUY	$11.59 - $17.73 $43,381 - $66,363	3,743 New	3,743 $64,000

Ticker AFIB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,370,300
Market Cap $1.99M
Description
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conv...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.